Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 77,475 |
|
|||||
| News | - | ||||||
| Day High | 0.80 | Low High |
|||||
| Day Low | 0.7601 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Kronos Bio Inc | KRON | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.01 | -1.27% | 0.78 | 11:11:23 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 0.80 | 0.7601 | 0.80 | 0.79 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 187 | 77,475 | US$ 0.777508 | US$ 60,237 | - | 0.69 - 2.29 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 11:12:42 | 5 | US$ 0.7704 | USD |
Kronos Bio Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 44.9M | 58.32M | - | 6.29M | -112.67M | -1.93 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Kronos Bio News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical KRON Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.76255 | 0.83 | 0.74 | 0.7762906 | 354,706 | 0.01745 | 2.29% |
| 1 Month | 1.02 | 1.09 | 0.69 | 0.9150137 | 421,164 | -0.24 | -23.53% |
| 3 Months | 1.35 | 1.40 | 0.69 | 1.01 | 384,943 | -0.57 | -42.22% |
| 6 Months | 1.18 | 1.5053 | 0.69 | 1.08 | 312,564 | -0.40 | -33.90% |
| 1 Year | 1.64 | 2.29 | 0.69 | 1.22 | 294,485 | -0.86 | -52.44% |
| 3 Years | 26.96 | 28.42 | 0.69 | 5.92 | 301,186 | -26.18 | -97.11% |
| 5 Years | 28.29 | 39.605 | 0.69 | 9.15 | 286,875 | -27.51 | -97.24% |
Kronos Bio Description
| Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine strategy by targeting dysregulated transcription. |
